Vigmed’s Board of Directors’ complete proposal for AGM May 13, 2015

Report this content

In accordance with previous published information, The Board of Directors is publishing the complete proposal for the election of Vigmed’s Board of Directors and Chairman as well as resolutions on authorizations for the Board of Directors to decide on a new share issue.

Election of the Board of Directors

Re-election of Lennart Holm, Mikael Karlsson, Richard Roos, Lennart Dreyer and Per Knutsson. Ulf Mossberg and Finn Ketler have decided not to stand for re-election. Ulf has decided to retire from the Board. Finn will step down from the Board in line with corporate governance principles and in order to have a clear demarcation between the roles of managing the company and the work of the Board.

Lennart Holm is proposed for re-election as Chairman of the Board. The Board proposes the election of two new board members as follows:

Dr. Thomas Baier - is from Germany and has a PHD in child cancer research. He has a long and successful international career with Roche Diagnostics. Since 2014 he has been working as a consultant in healthcare related businesses.

Axel Sjöblad – holds an MSc in Business and Economics with French orientation. He has had a long and successful international career with Gambro and since 2011, he is working for the Getinge Group where he today is the CEO of Getinge AB, Sweden.

"We are very pleased to present these additions to the Board, especially as we are now entering the European market with full force in order to take the next step in Vigmed’s development," says Vigmed’s Chairman, Lennart Holm.

For further information about the two proposed members, see attached pdf.

Resolutions on authorizations for the Board of Directors to decide on a new share issue

The Board proposes that the AGM authorizes the Board, to decide on new share issue, on one or more occasions during the period until the next AGM, with or without waiving shareholders preferential rights. 

For further details regarding resolutions on authorizations on a new share issue, see attached pdf.

For further information contact:

Chairman of the board, Lennart Holm +46 70 630 8562 or CEO, Finn Ketler +46 42 600 5311

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has approximately 20 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor.

Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s website: